Administrative and Public LawBanking and Financial Markets LitigationCivil Fraud, Asset Tracing and RecoveryCommercial LitigationCompetition LawConstruction and Engineering DisputesContentious Trusts, Estates and Private Wealth DisputesGroup Action LitigationInsolvency LitigationInsurance and Reinsurance LitigationInternational ArbitrationInvestigations and White Collar CrimeProduct LiabilityProfessional Negligence LitigationToxic Tort and ESG
Founded in 2012, Signature Litigation has grown into one of London’s pre-eminent specialist dispute resolution practices. From the outset, we set out to do things differently: a conflict-free, disputes-only platform designed to give clients the undivided focus and strategic agility that complex, high-stakes matters demand.
FIND OUT MORE
Established in 2017, Signature Litigation's Gibraltar office was founded to address growing demand for specialist expertise in commercial litigation and private wealth disputes on the Rock.
FIND OUT MORE
Signature Litigation AARPI houses one of France’s most enviable product liability practices, with the team also handling commercial and corporate litigation, insurance and reinsurance, toxic tort and ESG, civil fraud and asset tracing, international arbitration, administrative and public law.
FIND OUT MORE
Frankfurt has emerged as one of Europe's foremost financial and commercial centres and, increasingly, as a bridge between European and Asian markets. With that growth comes an increasing demand for sophisticated dispute resolution. Signature Litigation established its Frankfurt office to meet this need, bringing our conflict-free, disputes-only platform to the German market.
FIND OUT MOREPartner Sylvie Gallage-Alwis comments in relation to whether governments can sue vaccine producers for delays in delivering product, in Legal Week. Sylvie's comments were published in Legal Week, 29 January 2021, and can be found here. Her comments were also published in Legal Week's news analysis, 1 Feburary 2021, and can be found here.
“Typically, for a large-scale contract, there would not be specific dates, but a window of dates—a goal, say, of the end of a trimester—but always based on best efforts,” said Sylvie Gallage-Alwis, a partner at Signature Litigation in Paris.
“In every product-related contract, not delivering on time alone does not trigger breach,” Gallage-Alwis added. “There can be penalties for late delivery, often with a specific window of time before the penalties start.”
With vaccines for COVID-19, she said, “we’re in a very specific context—we’re talking about unprecedented large scale—so I’d be surprised if the contract didn’t provide for that.”
“Litigation takes a long time,” Gallage-Alwis said. “For most governments, it will not be seen as a good resource allocation.”
